2.94

10.64% -0.35

After Hours: 3.04 0.10 +3.40%

22nd Century Group, Inc. (XXII)

Overview News Price History Option Chain Discussions Forecast Stock Split

22nd Century Group, Inc. stock is traded at $2.94, with a volume of 46,152. It is down -10.64% in the last 24 hours and down -40.49% over the past month. 22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.

Previous Close:

$3.29

Open:

$3.16

24h Volume:

46,152

Relative Volume:

1.72

Market Cap:

$1.50M

Revenue:

$18.07M

Net Income/Loss:

$-14.58M

P/E Ratio:

-0.000463

EPS:

-6351.6506

Net Cash Flow:

$-15.01M

1W Performance:

-18.56%

1M Performance:

-40.49%

6M Performance:

-87.44%

1Y Performance:

-87.83%

1-Day Range:

$2.92

$3.2398

1-Week Range:

$2.92

$3.70

52-Week Range:

$2.92

$168.00

22nd Century Group, Inc. Stock (XXII) Company Profile

Name

22nd Century Group, Inc.

Sector

Healthcare (1113)

Industry

Biotechnology (623)

Phone

716-270-1523

Address

8560 Main Street, Williamsville, NY

Employee

Twitter

@_xxiicentury

Next Earnings Date

2026-03-26

Latest SEC Filings

XXII's Discussions on Twitter

Compare XXII vs VRTX, REGN, ALNY, ARGX, INSM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
XXII 22nd Century Group, Inc.	2.94	1.68M	18.07M	-14.58M	-15.01M	-6,351.65
VRTX Vertex Pharmaceuticals Inc	453.74	115.58B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	756.73	79.23B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	328.16	43.59B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	692.83	43.26B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	147.60	31.97B	606.42M	-1.28B	-997.58M	-6.403

22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-21-22	Initiated	Alliance Global Partners	Buy
Jun-15-22	Initiated	Craig Hallum	Buy
Mar-08-22	Initiated	ROTH Capital	Buy
Jul-23-21	Initiated	Cowen	Outperform
Oct-16-17	Reiterated	Chardan Capital Markets	Buy
Aug-11-16	Reiterated	Chardan Capital Markets	Buy

View All

22nd Century Group, Inc. Stock (XXII) Latest News

05:54 AM

22nd Century Group Reports Q4 and Full Year 2025 Results: VLN® Expansion, Higher Margins, and Debt-Free Growth - Minichart

05:54 AM

03:16 AM

22nd Century Group, Inc. 2025 Annual Report: VLN Reduced Nicotine Cigarettes, Risks, and Business Overview - Minichart

03:16 AM

02:04 AM